Search Results

There are 143688 results for: content related to: Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients

  1. You have free access to this content
    Optimising repeat prostate biopsy decisions and procedures

    BJU International

    Volume 109, Issue 12, June 2012, Pages: 1750–1754, Roger Kirby and John M. Fitzpatrick

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1464-410X.2011.10809.x

  2. You have free access to this content
    Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy

    Cancer

    Volume 121, Issue 22, November 15, 2015, Pages: 4071–4079, Selin Merdan, Scott A. Tomlins, Christine L. Barnett, Todd M. Morgan, James E. Montie, John T. Wei and Brian T. Denton

    Version of Record online : 17 AUG 2015, DOI: 10.1002/cncr.29611

  3. You have free access to this content
    Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies

    BJU International

    Volume 114, Issue 6b, December 2014, Pages: E56–E61, Stefano De Luca, Roberto Passera, Susanna Cappia, Enrico Bollito, Donato Franco Randone, Angela Milillo, Mauro Papotti and Francesco Porpiglia

    Version of Record online : 29 APR 2014, DOI: 10.1111/bju.12654

  4. You have free access to this content
    A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy

    BJU International

    Volume 109, Issue 11, June 2012, Pages: 1627–1635, Marco Auprich, Herbert Augustin, Lars Budäus, Luis Kluth, Sebastian Mannweiler, Shahrokh F. Shariat, Margit Fisch, Markus Graefen, Karl Pummer and Felix K.-H. Chun

    Version of Record online : 21 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10584.x

  5. Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia

    The Prostate

    Volume 75, Issue 10, July 1, 2015, Pages: 1102–1113, Tamara Sequeiros, Juan M. Bastarós, Milagros Sánchez, Marina Rigau, Melania Montes, José Placer, Jaques Planas, Inés de Torres, Jaume Reventós, D. Michiel Pegtel, Andreas Doll, Juan Morote and Mireia Olivan

    Version of Record online : 1 APR 2015, DOI: 10.1002/pros.22995

  6. You have free access to this content
    The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

    BJU International

    Volume 106, Issue 8, October 2010, Pages: 1143–1147, Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, Michael Marberger, Arnulf Stenzl, Peter F.A. Mulders, Hartwig Huland, Laurence Bastien, Clèment-Claude Abbou, Mesut Remzi, Martina Tinzl, Susan Feyerabend, Alexander B. Stillebroer, Martijn P.M.Q. Van Gils, Jack A. Schalken and Alexandre De La Taille

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1464-410X.2010.09286.x

  7. You have free access to this content
    The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance

    BJU International

    Volume 109, Issue 3, February 2012, Pages: 360–366, Hein van Poppel, Alexander Haese, Markus Graefen, Alexandre de la Taille, Jacques Irani, Theo de Reijke, Mesut Remzi and Michael Marberger

    Version of Record online : 26 AUG 2011, DOI: 10.1111/j.1464-410X.2011.10377.x

  8. You have free access to this content
    Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E778–E782, Stefano De Luca, Roberto Passera, Angela Milillo, Renato Coda and Donato Franco Randone

    Version of Record online : 1 NOV 2012, DOI: 10.1111/j.1464-410X.2012.11645.x

  9. You have free access to this content
    The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting

    BJU International

    Volume 108, Issue 11, December 2011, Pages: 1728–1733, Ahmed Adam, Matthys J. Engelbrecht, Maria S. Bornman, Samuel O. Manda, Evelyn Moshokoa and Rasmi A. Feilat

    Version of Record online : 20 APR 2011, DOI: 10.1111/j.1464-410X.2011.10202.x

  10. You have free access to this content
    Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1661–1665, Alessandro Sciarra, Valeria Panebianco, Susanna Cattarino, Gian Maria Busetto, Ettore De Berardinis, Mauro Ciccariello, Vincenzo Gentile and Stefano Salciccia

    Version of Record online : 4 MAY 2012, DOI: 10.1111/j.1464-410X.2012.11146.x

  11. You have free access to this content
    Rational approach to implementation of prostate cancer antigen 3 into clinical care

    Cancer

    Volume 115, Issue 17, 1 September 2009, Pages: 3879–3886, Rou Wang, Arul M. Chinnaiyan, Rodney L. Dunn, Kirk J. Wojno and John T. Wei

    Version of Record online : 10 JUN 2009, DOI: 10.1002/cncr.24447

  12. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy

    The Prostate

    Volume 75, Issue 16, December 1, 2015, Pages: 1951–1957, Ahmed Elshafei, K. Kent Chevli, Ayman S. Moussa, Onder Kara, Shih-Chieh Chueh, Peter Walter, Asmaa Hatem, Tianming Gao, J. Stephen Jones and Michael Duff

    Version of Record online : 18 SEP 2015, DOI: 10.1002/pros.23096

  13. You have free access to this content
    Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy

    BJU International

    Volume 111, Issue 6, May 2013, Pages: 928–933, Atsushi Ochiai, Koji Okihara, Kazumi Kamoi, Takehiro Oikawa, Toru Shimazui, Shin-Ichiro Murayama, Kyoichi Tomita, Tohru Umekawa, Hirotsugu Uemura and Tsuneharu Miki

    Version of Record online : 18 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11683.x

  14. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy

    The Prostate

    Volume 73, Issue 3, 15 February 2013, Pages: 227–235, Sisto Perdonà, Dario Bruzzese, Matteo Ferro, Riccardo Autorino, Ada Marino, Claudia Mazzarella, Giuseppe Perruolo, Michele Longo, Rosa Spinelli, Giuseppe Di Lorenzo, Andrea Oliva, Marco De Sio, Rocco Damiano, Vincenzo Altieri and Daniela Terracciano

    Version of Record online : 20 JUL 2012, DOI: 10.1002/pros.22561

  15. You have free access to this content
    Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy

    International Journal of Urology

    Volume 18, Issue 3, March 2011, Pages: 200–205, Atsushi Ochiai, Koji Okihara, Kazumi Kamoi, Tsuyoshi Iwata, Akihiro Kawauchi, Tsuneharu Miki and Zephyr Fors

    Version of Record online : 20 FEB 2011, DOI: 10.1111/j.1442-2042.2010.02711.x

  16. You have free access to this content
    Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?

    BJU International

    Volume 106, Issue 8, October 2010, Pages: 1138–1142, Mesut Remzi, Alexander Haese, Hein Van Poppel, Alexandre De La Taille, Arnulf Stenzl, Jörg Hennenlotter and Michael Marberger

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1464-410X.2010.09330.x

  17. You have free access to this content
    Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer

    BJU International

    Volume 114, Issue 4, October 2014, Pages: 608–616, Luis Martínez-Piñeiro, Jack A. Schalken, Patrick Cabri, Pascal Maisonobe, Alexandre de la Taille and on behalf of the Triptocare Study Group

    Version of Record online : 4 APR 2014, DOI: 10.1111/bju.12542

  18. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

    The Prostate

    Volume 70, Issue 1, 1 January 2010, Pages: 10–16, Daphne Hessels, Martijn P.M.Q. van Gils, Onno van Hooij, Sander A. Jannink, J. Alfred Witjes, Gerald W. Verhaegh and Jack A. Schalken

    Version of Record online : 25 AUG 2009, DOI: 10.1002/pros.21032

  19. You have free access to this content
    In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?

    BJU International

    Volume 115, Issue 4, April 2015, Pages: 562–570, Simpa S. Salami, Eran Ben-Levi, Oksana Yaskiv, Laura Ryniker, Baris Turkbey, Louis R. Kavoussi, Robert Villani and Ardeshir R. Rastinehad

    Version of Record online : 25 MAR 2015, DOI: 10.1111/bju.12938

  20. High prostate cancer gene 3 (PCA3) scores are associated with elevated Prostate Imaging Reporting and Data System (PI-RADS) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software-based targeted prostate biopsy after a previous negative standard biopsy

    BJU International

    Volume 118, Issue 5, November 2016, Pages: 723–730, Stefano De Luca, Roberto Passera, Giovanni Cattaneo, Matteo Manfredi, Fabrizio Mele, Cristian Fiori, Enrico Bollito, Stefano Cirillo and Francesco Porpiglia

    Version of Record online : 24 MAY 2016, DOI: 10.1111/bju.13504